Sanginita Chemicals Ltd. (SANGINITA) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): N/A
• Revenue Growth: 0.45%
• EPS Growth: -242.94%
• Country: IN
• Employees: 60
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): -1.07
• Shares Outstanding: N/A
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: -0.92
• Price to Book (P/B): 0.52
• Price to Sales (P/S): 0.13
• P/FCF Ratio: -3.49
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: ―

The score is primarily held back by weak and fragile financial performance—especially volatile operating cash flow and recurring negative free cash flow, alongside extremely thin margins. Balance-sheet leverage has improved, but low ROE suggests the stronger capital structure is not translating into strong returns. Technical and valuation inputs were not available, limiting non-fundamental conviction.

Positive Factors

Improving Leverage

The decline in debt-to-equity ratio indicates better financial health and reduced risk, providing more flexibility for future investments.

Balance Sheet Expansion

Growth in total assets suggests potential for increased operational capacity and long-term growth opportunities.

Governance Enhancement

Strengthening the compliance framework can improve governance and reduce regulatory risks, supporting sustainable business practices.

Negative Factors

Volatile Cash Flow

Inconsistent cash flow generation poses risks to financial stability and limits the company's ability to fund growth initiatives.

Negative Free Cash Flow

Persistent negative free cash flow indicates potential liquidity issues and challenges in sustaining operations without external financing.

Low Profitability

Extremely thin net margins highlight challenges in cost management and pricing power, affecting long-term profitability and competitiveness.

Sanginita Chemicals Ltd. Business Overview & Revenue Model

Company Description

Sanginita Chemicals Ltd. (SANGINITA) is a leading manufacturer and supplier of specialty chemicals, primarily focusing on the production of high-quality chemical intermediates and formulations for various industries, including agriculture, textiles, and pharmaceuticals. The company is committed to innovation and sustainability, offering a range of products that meet the evolving needs of its global clientele. With a robust research and development framework, SANGINITA aims to deliver cutting-edge solutions that enhance product performance and environmental safety.

How the Company Makes Money

Sanginita Chemicals Ltd. generates revenue through the sale of its specialty chemical products to various sectors, including agriculture, textiles, and pharmaceuticals. The company’s revenue model is primarily based on direct sales to manufacturers and distributors, which allows it to capture a wide market share across different industries. Key revenue streams include custom chemical formulations, bulk chemicals, and long-term contracts with major clients, which provide stable income. Additionally, SANGINITA may engage in strategic partnerships with other companies for joint ventures or collaborative product development, further enhancing its market presence and contributing to profitability.

Sanginita Chemicals Ltd. Financial Statement Overview

Summary

Financials are pressured by weak profitability (net margin ~0.3% in FY2025), volatile revenue, and especially poor/volatile cash generation with recurring negative free cash flow. The balance sheet is a partial offset with improving leverage (debt-to-equity down to ~0.47), but low ROE (~1.1%) signals limited value creation.

Income Statement

Revenue has been volatile, with a sharp drop in FY2022, modest recovery afterward, and a slight decline in FY2025 (annual) (-1.37%). Profitability is weak across the period: gross margin and EBITDA margin are low, and net margin is extremely thin (about 0.3% in FY2025). While earnings stayed positive, the company shows limited operating leverage and is vulnerable to cost inflation or pricing pressure.

Balance Sheet

Leverage looks manageable and improving: debt-to-equity declined to ~0.47 in FY2025 (annual) from ~0.81 in FY2024, supported by a higher equity base. Total assets have also grown, suggesting some balance-sheet expansion. The key weakness is low returns on equity (about 1.1% in FY2025), indicating the capital base is not generating strong profitability.

Cash Flow

Cash generation is the weakest area. Operating cash flow has been inconsistent, swinging from strong inflow (FY2023) to negative (FY2024) and only modestly positive in FY2025. Free cash flow is negative in multiple recent years and deteriorated materially in FY2025 (annual), implying heavy reinvestment and/or weak cash conversion. This volatility increases funding risk and reduces financial flexibility if profits soften.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.01B	2.30B	1.52B	1.49B	1.98B	1.65B
Gross Profit	56.06M	52.91M	49.17M	72.70M	61.60M	71.11M
EBITDA	37.34M	49.43M	44.09M	36.05M	31.10M	41.93M
Net Income	-4.83M	6.18M	7.70M	4.16M	3.48M	7.63M
Balance Sheet
Total Assets	1.02B	1.02B	859.29M	794.99M	792.04M	701.22M
Cash, Cash Equivalents and Short-Term Investments	133.00K	129.00K	205.00K	272.00K	149.00K	84.00K
Total Debt	263.72M	263.76M	328.66M	285.80M	345.14M	289.51M
Total Liabilities	468.23M	461.57M	451.35M	393.62M	394.83M	307.49M
Stockholders Equity	555.75M	561.45M	407.94M	401.37M	397.21M	393.73M
Cash Flow
Free Cash Flow	0.00	-83.50M	-62.01M	128.14M	-36.34M	82.32M
Operating Cash Flow	0.00	8.42M	-22.96M	137.01M	-29.88M	85.11M
Investing Cash Flow	0.00	-99.00M	-38.70M	-7.29M	-4.96M	-1.37M
Financing Cash Flow	0.00	90.51M	61.60M	-129.59M	34.90M	-83.93M

Sanginita Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
20MICRONS	74 Outperform	₹6.92B	11.09	―	0.63%	7.23%	5.00%
CHEMBOND	70 Outperform	₹2.12B	9.28	―	1.11%	-37.34%	-45.55%
BHAGERIA	63 Neutral	₹7.44B	14.60	―	0.81%	33.39%	85.08%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SADHNANIQ	51 Neutral	₹2.18B	-10.53	―	1.25%	-37.44%	-950.73%
SANGINITA	43 Neutral	―	―	―	―	0.45%	-242.94%

Sanginita Chemicals Ltd. Corporate Events

Sanginita Chemicals Files Q3 FY2025 Unaudited Results, Auditors Flag No Material Misstatements

Sanginita Chemicals Limited has reported its unaudited financial results for the quarter ended 31 December 2025, following approval by the board of directors at a meeting held on 10 January 2026. The company confirmed that its statutory auditors completed a limited review of the interim financial statements under applicable Indian accounting standards and SEBI regulations, with no material misstatements identified, and also declared that there has been no deviation or variation in the utilization of funds raised, signaling regulatory compliance and operational transparency for investors and other stakeholders.

Sanginita Chemicals Appoints New Compliance Officer

Sanginita Chemicals Ltd. has announced the appointment of Ms. Saroj Jagetia as the new Compliance Officer, effective November 1, 2025. This strategic appointment, based on the recommendation of the Nomination and Remuneration Committee, is expected to strengthen the company’s compliance framework and enhance its governance practices.